.

Deeper Knowledge, Faster

  • Identify first generic entrants
  • Drug patents and clinical trials in dozens of countries
  • Set up watchlists for daily email updates

► See Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Cantor Fitzgerald
Accenture
Medtronic
Farmers Insurance
McKesson
QuintilesIMS
Chinese Patent Office
Chubb
McKinsey
Mallinckrodt

Generated: June 23, 2017

DrugPatentWatch Database Preview

Dimenhydrinate - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for dimenhydrinate and what is the scope of dimenhydrinate freedom to operate?

Dimenhydrinate
is the generic ingredient in one branded drug marketed by Watson Labs Teva, Alra, Wyeth Ayerst, Fresenius Kabi Usa, Watson Labs, Heather, Baxter Hlthcare, and Nexgen Pharma Inc, and is included in nine NDAs. There is one patent protecting this compound. Additional information is available in the individual branded drug profile pages.

There are five drug master file entries for dimenhydrinate. One supplier is listed for this compound.

Summary for Generic Name: dimenhydrinate

Tradenames:1
Patents:1
Applicants:8
NDAs:9
Drug Master File Entries: see list5
Suppliers / Packagers: see list1
Bulk Api Vendors: see list35
Clinical Trials: see list12
Patent Applications: see list6,691
Therapeutic Class:Respiratory Tract Agents
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:dimenhydrinate at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Fresenius Kabi Usa
DIMENHYDRINATE
dimenhydrinate
INJECTABLE;INJECTION040519-001Jun 23, 2004RXNoYes► Subscribe► Subscribe
Watson Labs Teva
DIMENHYDRINATE
dimenhydrinate
INJECTABLE;INJECTION080615-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe
Heather
DIMENHYDRINATE
dimenhydrinate
TABLET;ORAL080841-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe
Wyeth Ayerst
DIMENHYDRINATE
dimenhydrinate
INJECTABLE;INJECTION084316-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe
Watson Labs
DIMENHYDRINATE
dimenhydrinate
TABLET;ORAL085166-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Deloitte
Medtronic
Novartis
Harvard Business School
Cerilliant
Chubb
Covington
Chinese Patent Office
Colorcon
Argus Health

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot